# The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older

> **NCT04587219** · PHASE2 · UNKNOWN · sponsor: **Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation** · enrollment: 110 (actual)

## Conditions studied

- Coronavirus Infection

## Interventions

- **BIOLOGICAL:** Gam-COVID-Vac

## Key facts

- **NCT ID:** NCT04587219
- **Lead sponsor:** Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-22
- **Primary completion:** 2021-03-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04587219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04587219, "The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04587219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*